Results 181 to 190 of about 36,146 (282)

High-Dose 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration: Who Is Being Treated with This New Agent? [PDF]

Life (Basel)
Liesenhoff C, Meyrl C, Krause D, Eckardt F, Lorger A, Deiters V, Schiefelbein J, Klaas JE, Schworm B, Priglinger SG, Siedlecki J.   +10 more
europepmc   +1 more source

Comparison of Neovascular Age-Related Macular Degeneration Outcomes in Established vs New Patients of a Retina Practice. [PDF]

J Vitreoretin Dis
Du J, Chen MY, Dasan R, Chen A, Kim G, Naidu A, Ebert J, Huang JM, Levinson JD, Ali MH, Do BK.   +10 more
europepmc   +1 more source

Correction to "Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

Navigating the Decision to Discontinue Intravitreal Injection Therapy in End-Stage Neovascular Age-Related Macular Degeneration. [PDF]

J Pers Med
Bennie J, Ramsey DJ.
europepmc   +1 more source

Evaluation of the Correlation of Reading Ability and Fixation Status in Patients With Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Miki R, Shiba T, Oshitari T, Usui T.
europepmc   +1 more source

Faricimab for Refractory Neovascular Age-Related Macular Degeneration: Retrospective Real-World Evidence from India. [PDF]

Clin Ophthalmol
Biswas RK, Sheth JU, Shrivastava V, Kaur J, Sinha S, Pal SS, Nandi K, Das S.   +7 more
europepmc   +1 more source

A systematic review on the effect of bevacizumab in exudative age-related macular degeneration [PDF]

, 2008

core   +1 more source

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]

, 2017
Eric Nudleman, Jeremy D. Wolfe, Maria A. Woodward, Yoshihiro Yonekawa, George Williams, T. Hassan   +5 more
openalex   +2 more sources

Secondary Angle Closure Glaucoma due to Massive Subretinal and Suprachoroidal Hemorrhage in Neovascular Age-Related Macular Degeneration: Clinical Case and Literature Review. [PDF]

Case Rep Ophthalmol Med
Nagaoka K, Makino S, Inoda S, Kaburaki T.   +3 more
europepmc   +1 more source

Switching From Aflibercept 2 mg to 8 mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration. [PDF]

Cureus
Tamai R, Nizawa T, Kawamata Y, Iwase T, Baba T.   +4 more
europepmc   +1 more source